Local Business Alert: Human Genome Services rejects buyout offer from GlaxoSmithKline

	Thursday, April 19, 2012 7:40:15 AM LOCAL BUSINESS ALERT Human Genome Services rejects buyout offer from GlaxoSmithKline Rockville-based Human Genome Sciences has rejected a buyout offer of $13 a share from British drugmaker GlaxoSmithKline, the company said Thursday. In a statement, the biotech company said the offer "does not reflect the value inherent" in the firm but would prompt the company to launch an evaluation of its "strategic alternatives." Read more at: http://www.washingtonpost.com/blogs/capital-business/post/human-genome-services-receives-buyout-offer-from-glaxosmithkline/2012/04/19/gIQAwThsST_blog.html Or visit PostBusiness.com or Capital Business. SEND TO A FRIEND UNSUBSCRIBE E-MAIL CENTER GET HELP Washington Post Digital E-mail Customer Care 1150 15th Street NW Washington, D.C. 20071  ©2011 The Washington Post Privacy Policy